Smith & Nephew shares slip on CFO's departure

Health Medical Technology & Services Written by: Ephrem Joseph 08:27 Wed 19 Aug 2026 --> Disclaimer No investment advice About this content Editorial Standards & Policies Share article About this content × About Ephrem Joseph Ephrem began his journalistic journey at Proactive in June 2021. With a strong academic background in Information Technology, his expertise particularly lies in the field of Cyber Security, Management Information Systems and Computer Forensics. Before joining Proactive, Ephrem worked as a researcher and lecturer at a number of leading universities, including the University of Portsmouth's Institute of Criminal Justice Studies, the University of Winchester’s Institute of Policing, and Jain... Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists. Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth. We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors. The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies. Use of technology Proactive has always been a forward looking and enthusiastic technology adopter. Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows. Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation. Smith & Nephew PLC ( LSE:SN ) View Price & Profile Smith & Nephew shares slip on CFO's departure Published: 08:27 19 Aug 2026 BST Smith & Nephew PLC (LSE:SN) share prices weakened around 3% after the company announced that chief financial officer John Rogers will leave the company at the end of September. The medical technology group's shares fell as low as 3.5% in early London trading to around 1,072p against Tuesday’s 1,110.5p close. Rogers will remain CFO until 30 September 2026 but has stepped down from the board with immediate effect. Smith+Nephew said it has begun a search for his successor. Pierre Palassian, senior vice president of finance and group controller, will serve as interim CFO until a permanent replacement is appointed. Palassian has more than 20 years of experience in finance leadership roles and has previously led finance functions across Smith+Nephew’s Global Operations, R&D, Advanced Wound Management, Sports Medicine, International Markets and Emerging Markets businesses. He joined the company in 2017 following senior roles at AbbVie and Abbott Laboratories (NYSE:ABT) . Chief executive Deepak Nath thanked Rogers for his contributions over the past 3 years, including work on the company’s 12-Point Plan, financial performance and development of its RISE strategy. Smith+Nephew said Rogers will continue to receive his normal salary, benefits and pension contributions until his departure, with no severance payment. Outstanding awards under the company’s Annual Incentive Plan, Performance Share Plan and Restricted Share Plan will lapse on 30 September in line with the relevant plan rules. Roger is leaving the company for an external role in the US. Continue reading